Filter posts

Results from the BIO Convention 2013 Meeting Analysis of Therapeutic In/Out Licensors

BIO’s results from the BIO 2013 Convention 1×1 meeting analysis conducted to identify trends and intentions …

AquAdvantage Salmon: A Regulatory Odyssey

At BIO 2012, an article was published on AquaBounty Technologies which told the tale of …

Alzheimer’s Disease “Robs You of Everything”

George Hendrick and his wife, Mary Lee, experienced the typical highs and lows of parenthood …

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s …

Biomedical R&D in the 21st Century

Reflecting back upon my career,  I recognize the importance academic-industry research partnerships played in shaping …

#BIO 2013: Open Innovation and Biopharmaceutical R&D

In these changing times, the concept of Open Innovation is one that we at AstraZeneca …

Natalie Ng wins the International BioGENEius Challenge

Today, Cupertino Junior Natalie Ng won the International BioGENEius Challenge, the premier competition for high …

Getting to Know Women in Bio

We caught up with Women In Bio’s President, Phyllis Dillinger, to learn more about the …

Panelists Talk GMOs at BIO Convention

On Monday at BIO’s International Convention, the U.S. Farmers & Ranchers Alliance (USFRA®) hosted The …

Q & A with Eli Lilly’s Eric Siemers

In October 2012, Eli Lilly and Company released results of its Expedition trials, two Phase …